Abstract
Neurofibromatosis type 1 (NF1) has been the subject of extensive research over the past decade, conducted by both French and international research groups. This work has led to significant advancements in the diagnosis, screening, and management of individuals with NF1. Current and future projects offer hope for new therapies targeting neurofibromas, whether plexiform or cutaneous, and effective against their malignant transformation.
Keywords :
Neurofibromatosis.
